144 related articles for article (PubMed ID: 2767871)
1. The morphologic characteristics of menstrual hemostasis in patients with unexplained menorrhagia.
Hourihan HM; Sheppard BL; Bonnar J
Int J Gynecol Pathol; 1989; 8(3):221-9. PubMed ID: 2767871
[TBL] [Abstract][Full Text] [Related]
2. Morphology of menstrual hemostasis in essential menorrhagia.
van Eijkeren MA; Christiaens GC; Geuze JJ; Haspels AA; Sixma JJ
Lab Invest; 1991 Feb; 64(2):284-94. PubMed ID: 1997737
[TBL] [Abstract][Full Text] [Related]
3. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia.
van Eijkeren MA; Christiaens GC; Geuze HJ; Haspels AA; Sixma JJ
Am J Obstet Gynecol; 1992 May; 166(5):1419-28. PubMed ID: 1595797
[TBL] [Abstract][Full Text] [Related]
4. Altered vascular smooth muscle cell differentiation in the endometrial vasculature in menorrhagia.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2014 Sep; 29(9):1884-94. PubMed ID: 25006206
[TBL] [Abstract][Full Text] [Related]
5. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
[TBL] [Abstract][Full Text] [Related]
6. Endometrial vascular development in heavy menstrual bleeding: altered spatio-temporal expression of endothelial cell markers and extracellular matrix components.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
Hum Reprod; 2018 Mar; 33(3):399-410. PubMed ID: 29309596
[TBL] [Abstract][Full Text] [Related]
7. Effects of a progesterone-releasing intrauterine contraceptive device on endometrial blood vessels: a morphometric study.
Shaw ST; Macaulay LK; Aznar R; González-Angulo A; Roy S
Am J Obstet Gynecol; 1981 Dec; 141(7):821-7. PubMed ID: 7315908
[TBL] [Abstract][Full Text] [Related]
8. Haemostasis in menstrual endometrium in the presence of an intrauterine device.
Christiaens GC; Sixma JJ; Haspels AA
Br J Obstet Gynaecol; 1981 Aug; 88(8):825-37. PubMed ID: 7260004
[TBL] [Abstract][Full Text] [Related]
9. Induction of endometrial plasminogen activator-inhibitor 1: a possible mechanism contributing to the effect of intrauterine levonorgestrel in the treatment of menorrhagia.
Rutanen E; Hurskainen R; Finne P; Nokelainen K
Fertil Steril; 2000 May; 73(5):1020-4. PubMed ID: 10785231
[TBL] [Abstract][Full Text] [Related]
10. Menstrual cycle distribution of uterine natural killer cells is altered in heavy menstrual bleeding.
Biswas Shivhare S; Bulmer JN; Innes BA; Hapangama DK; Lash GE
J Reprod Immunol; 2015 Nov; 112():88-94. PubMed ID: 26398782
[TBL] [Abstract][Full Text] [Related]
11. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
12. [Expression profile of aquaporin 1 in patients with menorrhagia].
Sun CC; Feng C; Zhou CY; Huang HF
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 36(5):433-8. PubMed ID: 17924459
[TBL] [Abstract][Full Text] [Related]
13. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
Pan J; Yu Y; Chen G
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
[TBL] [Abstract][Full Text] [Related]
14. Endothelial cell proliferation in the endometrium of women with menorrhagia and in women following endometrial ablation.
Kooy J; Taylor NH; Healy DL; Rogers PA
Hum Reprod; 1996 May; 11(5):1067-72. PubMed ID: 8671392
[TBL] [Abstract][Full Text] [Related]
15. Expression of aquaporin-1 in endometrial blood vessels in menorrhagia.
Mints M; Hildenbrand A; Lalitkumar LP; Andersson S; Nielsen S; Gemzell-Danielsson K; Stavreus-Evers A
Int J Mol Med; 2007 Mar; 19(3):407-11. PubMed ID: 17273788
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use.
Au CL; Affandi B; Rogers PA
Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456
[TBL] [Abstract][Full Text] [Related]
17. Cortisol inactivation by 11beta-hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via reduced thrombospondin-1 in heavy menstruation.
Rae M; Mohamad A; Price D; Hadoke PW; Walker BR; Mason JI; Hillier SG; Critchley HO
J Clin Endocrinol Metab; 2009 Apr; 94(4):1443-50. PubMed ID: 19158196
[TBL] [Abstract][Full Text] [Related]
18. The re-epithelization of endometrium after menstrual desquamation.
Ludwig H; Metzger H
Arch Gynakol; 1976; 221(1):51-60. PubMed ID: 989268
[TBL] [Abstract][Full Text] [Related]
19. Vascular smooth muscle alpha-actin distribution around endometrial arterioles during the menstrual cycle: increased expression during the perimenopause and lack of correlation with menorrhagia.
Abberton KM; Taylor NH; Healy DL; Rogers PA
Hum Reprod; 1996 Jan; 11(1):204-11. PubMed ID: 8671187
[TBL] [Abstract][Full Text] [Related]
20. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
